The Right Fit First: How Psychiatrists Approach Initial Treatment and Patient Adherence

In 'The Right Fit First: How Psychiatrists Approach Initial Treatment and Patient Adherence,' our panel of experts delve into the following critical questions:

1. What key factors drive your decision-making when choosing the first therapy for a patient?
2. How do you differentiate between nonadherence due to the disease versus nonadherence due to treatment adverse events?

Led by the moderator, the panelists discussed how the ultimate goal of first-line treatment selection should be remission, and that achieving it requires a careful, individualized assessment of a patient's short- and long-term side effect tolerability, prior medication history, and the specific clinical features of their presentation, rather than defaulting to a diagnosis alone as the primary guide for prescribing. The discussion also explored the pervasive and deeply human challenge of medication nonadherence, noting that between 60 and 80% of patients with serious mental illness do not take their prescriptions as directed, a reality that clinicians must approach with empathy and practical problem-solving rather than judgment, including simplifying regimens, addressing side effects proactively, and leveraging clinical pharmacists and specialty pharmacy partnerships to reinforce patient understanding at the point of dispensing. The panelists further highlighted how patient anxiety about prescribed medications, often amplified by internet research revealing rare side effects, underscores the importance of transparent, ongoing communication that frames treatment as a shared process, sets realistic expectations, and closes every encounter by inviting patients to ask whatever questions remain.

Throughout the conversation, the experts provide a comprehensive reflection on the field and the factors that may shape how clinicians approach care moving forward.

Our next episode, 'When Treatment Isn't Working: Defining Failure and Charting the Next Steps in Psychiatric Care,' further explores major depressive disorder, bipolar depression, and schizophrenia, highlighting how clinicians define treatment failure beyond clinical metrics, and the strategies they employ to determine whether to switch, augment, or build upon a current therapeutic regimen when a patient is not achieving adequate response.